{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T22:54:18Z","timestamp":1783551258063,"version":"3.55.0"},"reference-count":56,"publisher":"Walter de Gruyter GmbH","issue":"3-4","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Proteome-wide scale in a dose- and time-depending setting is crucial to fully understand the pharmacological mechanism of anticancer drugs as well as identification of candidates for drug response biomarkers. Here, we investigated the effect of the CIGB-300 anticancer peptide at IC<jats:sub>50<\/jats:sub> and IC<jats:sub>80<\/jats:sub> doses during 1 and 4\u202fh of treatment on the squamous lung cancer cell (NCI-H226) proteome. An overwhelming dose-dependent inhibitory effect with minor up-regulated proteins was observed by increasing CIGB-300 dose level. Functional enrichment was also CIGB-300 dose-dependent with common or exclusively regulated proteins in each dose and time settings. A protein core involving small molecule biosynthesis, aldehyde metabolism and metabolism of nucleobases was regulated irrespectively to the dose or the treatment time. Importantly, a group of proteins linked to NSCLC tumor biology, poor clinical outcome and some Protein Kinase CK2 substrates, were significantly regulated by treating with both CIGB-300 doses. Likewise, we observed a consistent downregulation of different proteins that had been already reported to be inhibited by CIGB-300 in lung adenocarcinoma and acute myeloid leukemia. Overall, our proteomics-guided strategy based on time and drug dose served to uncover novel clues supporting the CIGB-300 cytotoxic effect and also to identify putative pharmacodynamic biomarkers in NSCLC.<\/jats:p>","DOI":"10.1515\/hsz-2024-0149","type":"journal-article","created":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T11:56:51Z","timestamp":1745323011000},"page":"89-100","source":"Crossref","is-referenced-by-count":1,"title":["Time- and dose-dependent effects of CIGB-300 on the proteome of lung squamous cell carcinoma"],"prefix":"10.1515","volume":"406","author":[{"given":"Liudy","family":"Garc\u00eda-Hern\u00e1ndez","sequence":"first","affiliation":[{"name":"Department of System Biology , Center for Genetic Engineering & Biotechnology (CIGB) , 31 Ave , Havana 10600 , Cuba"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingfeng","family":"Dai","sequence":"additional","affiliation":[{"name":"Research Department, China-Cuba Biotechnology Joint Innovation Center (CCBJIC) , Yongzhou Zhong Gu Biotechnology Co., Ltd , Yangjiaqiao Street, Lengshuitan District , Yongzhou City 425000 , Hunan Province , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arielis","family":"Rodr\u00edguez-Ulloa","sequence":"additional","affiliation":[{"name":"Department of System Biology , Center for Genetic Engineering & Biotechnology (CIGB) , 31 Ave , Havana 10600 , Cuba"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Yi","sequence":"additional","affiliation":[{"name":"Research Department, China-Cuba Biotechnology Joint Innovation Center (CCBJIC) , Yongzhou Zhong Gu Biotechnology Co., Ltd , Yangjiaqiao Street, Lengshuitan District , Yongzhou City 425000 , Hunan Province , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis J.","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[{"name":"Department of System Biology , Center for Genetic Engineering & Biotechnology (CIGB) , 31 Ave , Havana 10600 , Cuba"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Besada","sequence":"additional","affiliation":[{"name":"Department of System Biology , Center for Genetic Engineering & Biotechnology (CIGB) , 31 Ave , Havana 10600 , Cuba"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Li","sequence":"additional","affiliation":[{"name":"Research Department, China-Cuba Biotechnology Joint Innovation Center (CCBJIC) , Yongzhou Zhong Gu Biotechnology Co., Ltd , Yangjiaqiao Street, Lengshuitan District , Yongzhou City 425000 , Hunan Province , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4224-0224","authenticated-orcid":false,"given":"Silvio E.","family":"Perea","sequence":"additional","affiliation":[{"name":"Department of Pharmaceuticals , Center for Genetic Engineering & Biotechnology (CIGB) , 31 Ave, Playa , Havana 10600 , Cuba"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasser","family":"Perera","sequence":"additional","affiliation":[{"name":"Research Department, China-Cuba Biotechnology Joint Innovation Center (CCBJIC) , Yongzhou Zhong Gu Biotechnology Co., Ltd , Yangjiaqiao Street, Lengshuitan District , Yongzhou City 425000 , Hunan Province , China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2025,4,23]]},"reference":[{"key":"2025071517592725721_j_hsz-2024-0149_ref_001","doi-asserted-by":"crossref","unstructured":"Ashburner, M., Ball, C.A., Blake, J.A., Botstein, D., Butler, H., Cherry, J.M., Davis, A.P., Dolinski, K., Dwight, S.S., Eppig, J.T., et al.. (2000). Gene ontology: tool for the unification of biology. The gene ontology consortium. Nat. Genet. 25: 25\u201329, https:\/\/doi.org\/10.1038\/75556.","DOI":"10.1038\/75556"},{"key":"2025071517592725721_j_hsz-2024-0149_ref_002","unstructured":"Batista-Albuerne, N., Gonz\u00e1lez-M\u00e9ndez, L., Garc\u00eda-Garc\u00eda, I., Sanchez, E., Garc\u00eda-Diegues, R., Torre-Santos, A.D., Mart\u00edn-Bauta, Y., Raices-Cruz, I., Valenzuela-Silva, C., Reyes-Nicolas, V., et al.. (2018). Phase I study of CIGB-300 administered intravenously in patients with relapsed\/refractory solid tumors. J.\u00a0Med. Oncol. 1: 4."},{"key":"2025071517592725721_j_hsz-2024-0149_ref_003","doi-asserted-by":"crossref","unstructured":"Borgo, C., D\u2019Amore, C., Sarno, S., Salvi, M., and Ruzzene, M. (2021). Protein kinase CK2: a potential therapeutic target for diverse human diseases. Signal Transduct. Targeted Ther. 6: 183, https:\/\/doi.org\/10.1038\/s41392-021-00567-7.","DOI":"10.1038\/s41392-021-00567-7"},{"key":"2025071517592725721_j_hsz-2024-0149_ref_004","doi-asserted-by":"crossref","unstructured":"Bray, F., Laversanne, M., Sung, H., Ferlay, J., Siegel, R.L., Soerjomataram, I., and Jemal, A. (2024). Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J.\u00a0Clin. 74: 229\u2013263, https:\/\/doi.org\/10.3322\/caac.21834.","DOI":"10.3322\/caac.21834"},{"key":"2025071517592725721_j_hsz-2024-0149_ref_005","doi-asserted-by":"crossref","unstructured":"Deng, H., Gao, Y., Trappetti, V., Hertig, D., Karatkevich, D., Losmanova, T., Urzi, C., Ge, H., Geest, G.A., Bruggmann, R., et al.. (2022). Targeting lactate dehydrogenase B-dependent mitochondrial metabolism affects tumor initiating cells and inhibits tumorigenesis of non-small cell lung cancer by inducing mtDNA damage. Cell. Mol. Life Sci. 79: 445, https:\/\/doi.org\/10.1007\/s00018-022-04453-5.","DOI":"10.1007\/s00018-022-04453-5"},{"key":"2025071517592725721_j_hsz-2024-0149_ref_006","doi-asserted-by":"crossref","unstructured":"Deng, H., Hang, Q., Shen, D., Ying, H., Zhang, Y., Qian, X., and Chen, M. (2021). High expression levels of CDK1 and CDC20 in patients with lung squamous cell carcinoma are associated with worse prognosis. Front. Mol. Biosci. 8: 653805, https:\/\/doi.org\/10.3389\/fmolb.2021.653805.","DOI":"10.3389\/fmolb.2021.653805"},{"key":"2025071517592725721_j_hsz-2024-0149_ref_007","doi-asserted-by":"crossref","unstructured":"Dogan Turacli, I., Ozkan, A.C., and Ekmekci, A. (2015). The comparison between dual inhibition of mTOR with MAPK and PI3K signaling pathways in KRAS mutant NSCLC cell lines. Tumor Biol. 36: 9339\u20139345, https:\/\/doi.org\/10.1007\/s13277-015-3671-0.","DOI":"10.1007\/s13277-015-3671-0"},{"key":"2025071517592725721_j_hsz-2024-0149_ref_008","doi-asserted-by":"crossref","unstructured":"Du, S., Guan, Z., Hao, L., Song, Y., Wang, L., Gong, L., Liu, L., Qi, X., Hou, Z., and Shao, S. (2014). Fructose-bisphosphate aldolase A is a potential metastasis-associated marker of lung squamous cell carcinoma and promotes lung cell tumorigenesis and migration. PLoS ONE 9: e85804, https:\/\/doi.org\/10.1371\/journal.pone.0085804.","DOI":"10.1371\/journal.pone.0085804"},{"key":"2025071517592725721_j_hsz-2024-0149_ref_009","doi-asserted-by":"crossref","unstructured":"Fiume, L. (1960). Inhibition of aerobic glycolysis in Yoshida Ascites Hepatoma by tartronic acid. Nature 187: 792\u2013793, https:\/\/doi.org\/10.1038\/187792a0.","DOI":"10.1038\/187792a0"},{"key":"2025071517592725721_j_hsz-2024-0149_ref_010","doi-asserted-by":"crossref","unstructured":"Gillespie, M., Jassal, B., Stephan, R., Milacic, M., Rothfels, K., Senff-Ribeiro, A., Griss, J., Sevilla, C., Matthews, L., Gong, C., et al.. (2022). The reactome pathway knowledgebase 2022. Nucleic Acids Res. 50: D687\u2013D692, https:\/\/doi.org\/10.1093\/nar\/gkab1028.","DOI":"10.1093\/nar\/gkab1028"},{"key":"2025071517592725721_j_hsz-2024-0149_ref_011","doi-asserted-by":"crossref","unstructured":"Goldman, J.W. and Garon, E.B. (2012). Targeting MEK for the treatment of non-small-cell lung cancer. J.\u00a0Thorac. Oncol. 16: S377\u2013S378, https:\/\/doi.org\/10.1097\/jto.0b013e31826df0bc.","DOI":"10.1097\/JTO.0b013e31826df0bc"},{"key":"2025071517592725721_j_hsz-2024-0149_ref_012","doi-asserted-by":"crossref","unstructured":"Gu, M.M., Gao, D., Yao, P.A., Yu, L., Yang, X.D., Xing, C.G., Zhou, J., Shang, Z.F., and Li, M. (2018). p53-inducible gene 3 promotes cell migration and invasion by activating the FAK\/Src pathway in lung adenocarcinoma. Cancer Sci. 109: 3783\u20133793, https:\/\/doi.org\/10.1111\/cas.13818.","DOI":"10.1111\/cas.13818"},{"key":"2025071517592725721_j_hsz-2024-0149_ref_013","doi-asserted-by":"crossref","unstructured":"He, F., Ru, X., and Wen, T. (2020). NRF2, a transcription factor for stress response and beyond. Int. J.\u00a0Mol. Sci. 21: 4777, https:\/\/doi.org\/10.3390\/ijms21134777.","DOI":"10.3390\/ijms21134777"},{"key":"2025071517592725721_j_hsz-2024-0149_ref_014","doi-asserted-by":"crossref","unstructured":"Herbst, R.S., Morgensztern, D., and Boshoff, C. (2018). The biology and management of non-small cell lung cancer. Nature 553: 446\u2013454, https:\/\/doi.org\/10.1038\/nature25183.","DOI":"10.1038\/nature25183"},{"key":"2025071517592725721_j_hsz-2024-0149_ref_015","doi-asserted-by":"crossref","unstructured":"Hornbeck, P.V., Kornhauser, J.M., Latham, V., Murray, B., Nandhikonda, V., Nord, A., Skrzypek, E., Wheeler, T., Zhang, B., and Gnad, F. (2019). 15\u00a0years of PhosphoSitePlus\u00ae: integrating post-translationally modified sites, disease variants and isoforms. Nucleic Acids Res. 47: D433\u2013D441, https:\/\/doi.org\/10.1093\/nar\/gky1159.","DOI":"10.1093\/nar\/gky1159"},{"key":"2025071517592725721_j_hsz-2024-0149_ref_016","doi-asserted-by":"crossref","unstructured":"Jin, H., Cheng, X., Pei, Y., Fu, J., Lyu, Z., Peng, H., Yao, Q., Jiang, Y., Luo, L., and Zhuo, H. (2016). Identification and verification of transgelin-2 as a potential biomarker of tumor-derived lung-cancer endothelial cells by comparative proteomics. J.\u00a0Proteomics 136: 77\u201388, https:\/\/doi.org\/10.1016\/j.jprot.2015.12.012.","DOI":"10.1016\/j.jprot.2015.12.012"},{"key":"2025071517592725721_j_hsz-2024-0149_ref_017","doi-asserted-by":"crossref","unstructured":"Kanehisa, M. and Goto, S. (2000). KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28: 27\u201330, https:\/\/doi.org\/10.1093\/nar\/28.1.27.","DOI":"10.1093\/nar\/28.1.27"},{"key":"2025071517592725721_j_hsz-2024-0149_ref_018","doi-asserted-by":"crossref","unstructured":"Kim, J.W., Botvinnik, O.B., Abudayyeh, O., Birger, C., Rosenbluh, J., Shrestha, Y., Abazeed, M.E., Hammerman, P.S., DiCara, D., Konieczkowski, D.J., et al.. (2016). Characterizing genomic alterations in cancer by complementary functional associations. Nat. Biotechnol. 34: 539\u2013546, https:\/\/doi.org\/10.1038\/nbt.3527.","DOI":"10.1038\/nbt.3527"},{"key":"2025071517592725721_j_hsz-2024-0149_ref_019","doi-asserted-by":"crossref","unstructured":"Li, M., Li, S., Liu, B., Gu, M.M., Zou, S., Xiao, B.B., Yu, L., Ding, W.Q., Zhou, P.K., Zhou, J., et al.. (2017). PIG3 promotes NSCLC cell mitotic progression and is associated with poor prognosis of NSCLC patients. J.\u00a0Exp. Clin. Cancer Res. 36: 39, https:\/\/doi.org\/10.1186\/s13046-017-0508-2.","DOI":"10.1186\/s13046-017-0508-2"},{"key":"2025071517592725721_j_hsz-2024-0149_ref_020","doi-asserted-by":"crossref","unstructured":"Li, M., Yang, X., Zhang, G., Wang, L., Zhu, Z., Zhang, W., Huang, H., and Gao, R. (2022). Heterogeneous nuclear ribonucleoprotein K promotes the progression of lung cancer by inhibiting the p53-dependent signaling pathway. Thorac. Cancer 13: 1311\u20131321, https:\/\/doi.org\/10.1111\/1759-7714.14387.","DOI":"10.1111\/1759-7714.14387"},{"key":"2025071517592725721_j_hsz-2024-0149_ref_021","doi-asserted-by":"crossref","unstructured":"Liao, R.G., Watanabe, H., Meyerson, M., and Hammerman, P.S. (2012). Targeted therapy for squamous cell lung cancer. Lung Cancer Manage. 1: 293\u2013300, https:\/\/doi.org\/10.2217\/lmt.12.40.","DOI":"10.2217\/lmt.12.40"},{"key":"2025071517592725721_j_hsz-2024-0149_ref_022","doi-asserted-by":"crossref","unstructured":"Liberti, M.V. and Locasale, J.W. (2016). The Warburg effect: how does it benefit cancer cells? Trends Biochem. Sci. 41: 211\u2013218, https:\/\/doi.org\/10.1016\/j.tibs.2015.12.001.","DOI":"10.1016\/j.tibs.2015.12.001"},{"key":"2025071517592725721_j_hsz-2024-0149_ref_023","doi-asserted-by":"crossref","unstructured":"Liberzon, A., Birger, C., Thorvaldsd\u00f3ttir, H., Ghandi, M., Mesirov, J.P., and Tamayo, P. (2015). The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst. 23: 417\u2013425, https:\/\/doi.org\/10.1016\/j.cels.2015.12.004.","DOI":"10.1016\/j.cels.2015.12.004"},{"key":"2025071517592725721_j_hsz-2024-0149_ref_024","doi-asserted-by":"crossref","unstructured":"Lin, L., Wu, Q., Lu, F., Lei, J., Zhou, Y., Liu, Y., Zhu, N., Yu, Y., Ning, Z., She, T., et al.. (2023). Nrf2 signaling pathway: current status and potential therapeutic targetable role in human cancers. Front. Oncol. 22: 1184079, https:\/\/doi.org\/10.3389\/fonc.2023.1184079.","DOI":"10.3389\/fonc.2023.1184079"},{"key":"2025071517592725721_j_hsz-2024-0149_ref_025","doi-asserted-by":"crossref","unstructured":"Ling, X.L., Zhang, T., Hou, X.M., and Zhao, D. (2015). Clinicopathological significance of fascin-1 expression in patients with non-small cell lung cancer. Onco. Targets Ther. 30: 1589\u20131595, https:\/\/doi.org\/10.2147\/ott.s84308.","DOI":"10.2147\/OTT.S84308"},{"key":"2025071517592725721_j_hsz-2024-0149_ref_026","doi-asserted-by":"crossref","unstructured":"Matsuda, M., Ninomiya, H., Wakejima, R., Inamura, K., Okumura, S., Mun, M., Kitagawa, M., and Ishikawa, Y. (2020). Calretinin-expressing lung adenocarcinoma: distinct characteristics of advanced stages, smoker-type features, and rare expression of other mesothelial markers are useful to differentiate epithelioid mesothelioma. Pathol. Res. Pract. 216: 152817, https:\/\/doi.org\/10.1016\/j.prp.2020.152817.","DOI":"10.1016\/j.prp.2020.152817"},{"key":"2025071517592725721_j_hsz-2024-0149_ref_027","doi-asserted-by":"crossref","unstructured":"McCleland, M.L., Adler, A.S., Deming, L., Cosino, E., Lee, L., Blackwood, E.M., Solon, M., Tao, J., Li, L., Shames, D., et al.. (2013). Lactate dehydrogenase B is required for the growth of KRAS-dependent lung adenocarcinomas. Clin. Cancer Res. 19: 773\u2013784, https:\/\/doi.org\/10.1158\/1078-0432.ccr-12-2638.","DOI":"10.1158\/1078-0432.CCR-12-2638"},{"key":"2025071517592725721_j_hsz-2024-0149_ref_028","doi-asserted-by":"crossref","unstructured":"Nian, H. and Ma, B. (2021). Calpain-calpastatin system and cancer progression. Biol. Rev. Camb. Philos. Soc. 96: 961\u2013975, https:\/\/doi.org\/10.1111\/brv.12686.","DOI":"10.1111\/brv.12686"},{"key":"2025071517592725721_j_hsz-2024-0149_ref_029","doi-asserted-by":"crossref","unstructured":"Niu, M., Shan, M., Liu, Y., Song, Y., Han, J.-g., Sun, S., and Zhang, G.Q. (2021). DCTPP1, an oncogene regulated by miR-378a-3p, promotes proliferation of breast cancer via DNA repair signaling pathway. Front. Oncol. 11: 641931, https:\/\/doi.org\/10.3389\/fonc.2021.641931.","DOI":"10.3389\/fonc.2021.641931"},{"key":"2025071517592725721_j_hsz-2024-0149_ref_030","doi-asserted-by":"crossref","unstructured":"Niu, Z., Jin, R., Zhang, Y., and Li, H. (2022). Signaling pathways and targeted therapies in lung squamous cell carcinoma: mechanisms and clinical trials. Signal Transduct. Targeted Ther. 7: 353, https:\/\/doi.org\/10.1038\/s41392-022-01200-x.","DOI":"10.1038\/s41392-022-01200-x"},{"key":"2025071517592725721_j_hsz-2024-0149_ref_031","doi-asserted-by":"crossref","unstructured":"Pelisch, F., Pozzi, B., Risso, G., Mu\u00f1oz, M.J., and Srebrow, A. (2012). DNA damage-induced heterogeneous nuclear ribonucleoprotein K sumoylation regulates p53 transcriptional activation. J.\u00a0Biol. Chem. 287: 30789\u201330799, https:\/\/doi.org\/10.1074\/jbc.m112.390120.","DOI":"10.1074\/jbc.M112.390120"},{"key":"2025071517592725721_j_hsz-2024-0149_ref_032","doi-asserted-by":"crossref","unstructured":"Perea, S.E., Reyes, O., Puchades, Y., Mendoza, O., Vispo, N.S., Torrens, I., Santos, A., Silva, R., Acevedo, B., L\u00f3pez, E., et al.. (2004). Antitumor effect of a novel proapoptotic peptide that impairs the phosphorylation by the protein kinase 2 (casein kinase 2). Cancer Res. 64: 7127\u20137129, https:\/\/doi.org\/10.1158\/0008-5472.can-04-2086.","DOI":"10.1158\/0008-5472.CAN-04-2086"},{"key":"2025071517592725721_j_hsz-2024-0149_ref_033","doi-asserted-by":"crossref","unstructured":"Perea, S.E., Reyes, O., Baladron, I., Perera, Y., Farina, H., Gil, J., Rodr\u00edguez, A., Bacard\u00ed, D., Marcelo, J.L., Cosme, K., et al.. (2008). CIGB-300, a novel proapoptotic peptide that impairs the CK2 phosphorylation and exhibits anticancer properties both in\u00a0vitro and in\u00a0vivo. Mol. Cell. Biochem. 316: 163\u2013167, https:\/\/doi.org\/10.1007\/s11010-008-9814-5.","DOI":"10.1007\/s11010-008-9814-5"},{"key":"2025071517592725721_j_hsz-2024-0149_ref_034","doi-asserted-by":"crossref","unstructured":"Perea, S.E., Baladr\u00f3n, I., Valenzuela, C., and Perera, Y. (2018). CIGB-300: a peptide-based drug that impairs the protein kinase CK2-mediated phosphorylation. Semin. Oncol. 45: 58\u201367, https:\/\/doi.org\/10.1053\/j.seminoncol.2018.04.006.","DOI":"10.1053\/j.seminoncol.2018.04.006"},{"key":"2025071517592725721_j_hsz-2024-0149_ref_035","doi-asserted-by":"crossref","unstructured":"Perera, Y., Farina, H.G., Gil, J., Rodriguez, A., Benavent, F., Castellanos, L., G\u00f3mez, R.E., Acevedo, B.E., Alonso, D.F., Perea, S.E., et al.. (2009). Anticancer peptide CIGB-300 binds to nucleophosmin\/B23, impairs its CK2-mediated phosphorylation, and leads to apoptosis through its nucleolar disassembly activity. Mol. Cancer Ther. 8: 1189\u20131196, https:\/\/doi.org\/10.1158\/1535-7163.mct-08-1056.","DOI":"10.1158\/1535-7163.MCT-08-1056"},{"key":"2025071517592725721_j_hsz-2024-0149_ref_036","doi-asserted-by":"crossref","unstructured":"Perera, Y., Ramos, Y., Padr\u00f3n, G., Caballero, E., Guirola, O., Caligiuri, L.G., Lorenzo, N., Gottardo, F., Farina, H.G., Filhol, O., et al.. (2020). CIGB-300 anticancer peptide regulates the protein kinase CK2-dependent phosphoproteome. Mol. Cell. Biochem. 470: 63\u201375, https:\/\/doi.org\/10.1007\/s11010-020-03747-1.","DOI":"10.1007\/s11010-020-03747-1"},{"key":"2025071517592725721_j_hsz-2024-0149_ref_037","doi-asserted-by":"crossref","unstructured":"Perera, Y., Pedroso, S., Borras-Hidalgo, O., V\u00e1zquez, D.M., Miranda, J., Villareal, A., Falc\u00f3n, V., Cruz, L.D., Farinas, H.G., and Perea, S.E. (2015). Pharmacologic inhibition of the CK2-mediated phosphorylation of B23\/NPM in cancer cells selectively modulates genes related to protein synthesis, energetic metabolism, and ribosomal biogenesis. Mol. Cel. Biochem. 404: 103\u2013112, https:\/\/doi.org\/10.1007\/s11010-015-2370-x.","DOI":"10.1007\/s11010-015-2370-x"},{"key":"2025071517592725721_j_hsz-2024-0149_ref_038","doi-asserted-by":"crossref","unstructured":"P\u00e9rez, G.V., Rosales, M., Ram\u00f3n, A.C., Rodr\u00edguez-Ulloa, A., Besada, V., Gonz\u00e1lez, L.J., Aguilar, D., V\u00e1zquez-Blomquist, D., Falc\u00f3n, V., Caballero, E., et al.. (2023). CIGB-300 anticancer peptide differentially interacts with CK2 subunits and regulates specific signaling mediators in a highly sensitive Large cell lung carcinoma cell model. Biomedicines 11: 43.","DOI":"10.3390\/biomedicines11010043"},{"key":"2025071517592725721_j_hsz-2024-0149_ref_039","doi-asserted-by":"crossref","unstructured":"Pi, J., Bai, Y., Reece, J.M., Williams, J., Liu, D., Freeman, M.L., Fahl, W.E., Shugar, D., Liu, J., Qu, W., et al.. (2007). Molecular mechanism of human Nrf2 activation and degradation: role of sequential phosphorylation by protein kinase CK2. Free Radic. Biol. Med. 42: 1797\u20131806, https:\/\/doi.org\/10.1016\/j.freeradbiomed.2007.03.001.","DOI":"10.1016\/j.freeradbiomed.2007.03.001"},{"key":"2025071517592725721_j_hsz-2024-0149_ref_040","doi-asserted-by":"crossref","unstructured":"Plotnikov, A., Chuderland, D., Karamansha, Y., Livnah, O., and Seger, R. (2019). Nuclear ERK translocation is mediated by protein kinase CK2 and accelerated by autophosphorylation. Cell. Physiol. Biochem. 53: 366\u2013387, https:\/\/doi.org\/10.33594\/000000144.","DOI":"10.33594\/000000144"},{"key":"2025071517592725721_j_hsz-2024-0149_ref_041","doi-asserted-by":"crossref","unstructured":"Rodr\u00edguez-Ulloa, A., Ramos, Y., Gil, J., Perera, Y., Castellanos-Serra, L.R., Garc\u00eda, Y., Betancourt, L.H., Besada, V., Gonz\u00e1lez, L.J., Fern\u00e1ndez-de-Cossio, J., et al.. (2010). Proteomic profile regulated by the anticancer peptide CIGB-300 in non-small cell lung cancer (NSCLC) cells. J.\u00a0Proteome Res. 9: 5473\u20135483, https:\/\/doi.org\/10.1021\/pr100728v.","DOI":"10.1021\/pr100728v"},{"key":"2025071517592725721_j_hsz-2024-0149_ref_043","doi-asserted-by":"crossref","unstructured":"Rosales, M., P\u00e9rez, G.V., Ram\u00f3n, A.C., Cruz, Y., Rodr\u00edguez-Ulloa, A., Besada, V., Ramos, Y., V\u00e1zquez-Blomquist, D., Caballero, E., Aguilar, D., et al.. (2021). Targeting of protein kinase CK2 in acute myeloid leukemia cells using the clinical-grade synthetic-peptide CIGB-300. Biomedicines 9: 766, https:\/\/doi.org\/10.3390\/biomedicines9070766.","DOI":"10.3390\/biomedicines9070766"},{"key":"2025071517592725721_j_hsz-2024-0149_ref_044","doi-asserted-by":"crossref","unstructured":"Rosales, M., Rodr\u00edguez-Ulloa, A., P\u00e9rez, G.V., Besada, V., Soto, T., Ramos, Y., Gonz\u00e1lez, L.J., Zettl, K., Wi\u015bniewski, J.R., Yang, K., et al.. (2022). CIGB-300-Regulated proteome reveals common and tailored response patterns of AML Cells to CK2 inhibition. Front. Mol. Biosci. 9: 834814, https:\/\/doi.org\/10.3389\/fmolb.2022.834814.","DOI":"10.3389\/fmolb.2022.834814"},{"key":"2025071517592725721_j_hsz-2024-0149_ref_045","doi-asserted-by":"crossref","unstructured":"Ruzzene, M. and Pinna, L.A. (2010). Addiction to protein kinase CK2: a common denominator of diverse cancer cells? Biochim. Biophys. Acta Proteins Proteom. 1804: 499\u2013504, https:\/\/doi.org\/10.1016\/j.bbapap.2009.07.018.","DOI":"10.1016\/j.bbapap.2009.07.018"},{"key":"2025071517592725721_j_hsz-2024-0149_ref_046","doi-asserted-by":"crossref","unstructured":"Shannon, P., Markiel, A., Ozier, O., Baliga, N.S., Wang, J.T., Ramage, D., Amin, N., Schwikowski, B., and Cytoscape, I. T. (2003). A software environment for integrated models of biomolecular interaction networks. Genome Res. 13: 2498\u20132504, https:\/\/doi.org\/10.1101\/gr.1239303.","DOI":"10.1101\/gr.1239303"},{"key":"2025071517592725721_j_hsz-2024-0149_ref_047","doi-asserted-by":"crossref","unstructured":"Strefeler, A., Blanco-Fernandez, J., and Jourdain, A.A. (2024). Nucleosides are overlooked fuels in central carbon metabolism. Trends Endocrinol. Metab. 35: 290\u2013299, https:\/\/doi.org\/10.1016\/j.tem.2024.01.013.","DOI":"10.1016\/j.tem.2024.01.013"},{"key":"2025071517592725721_j_hsz-2024-0149_ref_048","doi-asserted-by":"crossref","unstructured":"Szklarczyk, D., Gable, A.L., Lyon, D., Junge, A., Wyder, S., Huerta-Cepas, J., Simonovic, M., Doncheva, N.T., Morris, J.H., Bork, P., et al.. (2019). STRING v11: protein\u2013protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 47: D607\u2013D613, https:\/\/doi.org\/10.1093\/nar\/gky1131.","DOI":"10.1093\/nar\/gky1131"},{"key":"2025071517592725721_j_hsz-2024-0149_ref_049","doi-asserted-by":"crossref","unstructured":"Tang, F. and Cui, Q. (2024). Diverse roles of aldolase enzymes in cancer development, drug resistance and therapeutic approaches as moonlighting enzymes. Med. Oncol. 41: 224, https:\/\/doi.org\/10.1007\/s12032-024-02470-x.","DOI":"10.1007\/s12032-024-02470-x"},{"key":"2025071517592725721_j_hsz-2024-0149_ref_050","doi-asserted-by":"crossref","unstructured":"Wi\u015bniewski, J.R., Zougman, A., Nagaraj, N., and Mann, M. (2009). Universal sample preparation method for proteome analysis. Nat. Methods 6: 359\u2013362, https:\/\/doi.org\/10.1038\/nmeth.1322.","DOI":"10.1038\/nmeth.1322"},{"key":"2025071517592725721_j_hsz-2024-0149_ref_051","doi-asserted-by":"crossref","unstructured":"Xu, F., Gu, J., Lu, C., Mao, W., Wang, L., Zhu, Q., Liu, Z., Chu, Y., Liu, R., and Ge, D. (2019). Calpain-2 enhances non-small cell lung cancer progression and chemoresistance to paclitaxel via EGFR-pAKT pathway. Int. J.\u00a0Biol. Sci. 15: 127\u2013137, https:\/\/doi.org\/10.7150\/ijbs.28834.","DOI":"10.7150\/ijbs.28834"},{"key":"2025071517592725721_j_hsz-2024-0149_ref_052","doi-asserted-by":"crossref","unstructured":"Yang, Y., Chong, Y., Chen, M., Dai, W., Zhou, X., Ji, Y., Qiu, G., and Du, X. (2021). Targeting lactate dehydrogenase a improves radiotherapy efficacy in non-small cell lung cancer: from bedside to bench. J.\u00a0Transl. Med. 19: 170, https:\/\/doi.org\/10.1186\/s12967-021-02825-2.","DOI":"10.1186\/s12967-021-02825-2"},{"key":"2025071517592725721_j_hsz-2024-0149_ref_053","doi-asserted-by":"crossref","unstructured":"Yi, Y., Dai, L., Lan, Y., Tan, Ch., V\u00e1zquez-Blomquist, D.M., Zeng, G., Jiang, D., Yang, K., Perea, S.E., and Perera, Y. (2024). CIGB-300 internalizes and impairs viability of NSCLC cells lacking actionable targets by inhibiting casein kinase-2 signaling. Sci. Rep. 14: 26038, https:\/\/doi.org\/10.1038\/s41598-024-75990-1.","DOI":"10.1038\/s41598-024-75990-1"},{"key":"2025071517592725721_j_hsz-2024-0149_ref_054","doi-asserted-by":"crossref","unstructured":"Zecha, J., Bayer, F.P., Wiechmann, S., Woortman, J., Berne, R. N., M\u00fcller, J., Schneider, A., Kramer, K., Abril-Gil, M., Hopf, T., et al.. (2023). Decrypting drug actions and protein modifications by dose- and time-resolved proteomics. Science 380: 93\u2013101, https:\/\/doi.org\/10.1126\/science.ade3925.","DOI":"10.1126\/science.ade3925"},{"key":"2025071517592725721_j_hsz-2024-0149_ref_056","doi-asserted-by":"crossref","unstructured":"Zhang, Y., Ye, W.Y., Wang, J.Q., Wang, S.J., Ji, P., Zhou, G.Y., Zhao, G.P., Ge, H.L., and Wang, Y. (2013). dCTP pyrophosphohydrase exhibits nucleic accumulation in multiple carcinomas. Eur. J.\u00a0Histochem. 57: e29, https:\/\/doi.org\/10.4081\/ejh.2013.e29.","DOI":"10.4081\/ejh.2013.e29"},{"key":"2025071517592725721_j_hsz-2024-0149_ref_057","doi-asserted-by":"crossref","unstructured":"Zheng, Y., Qin, H., Frank, S.J., Deng, L., Litchfield, D.W., Tefferi, A., Pardanani, A., Lin, F.T., Li, J., Sha, B., et al.. (2011). A CK2-dependent mechanism for activation of the JAK-STAT signaling pathway. Blood 118: 156\u2013166, https:\/\/doi.org\/10.1182\/blood-2010-01-266320.","DOI":"10.1182\/blood-2010-01-266320"},{"key":"2025071517592725721_j_hsz-2024-0149_ref_058","doi-asserted-by":"crossref","unstructured":"Zhou, Y., Zhou, B., Pache, L., Chang, M., Khodabakhshi, A.H., Tanaseichuk, O., Benner, C.W., and Chanda, S.K. (2019). Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat. Commun. 10: 1523, https:\/\/doi.org\/10.1038\/s41467-019-09234-6.","DOI":"10.1038\/s41467-019-09234-6"}],"container-title":["Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/hsz-2024-0149\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/hsz-2024-0149\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T18:00:31Z","timestamp":1752602431000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/hsz-2024-0149\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,1]]},"references-count":56,"journal-issue":{"issue":"3-4","published-online":{"date-parts":[[2025,6,3]]},"published-print":{"date-parts":[[2025,3,26]]}},"alternative-id":["10.1515\/hsz-2024-0149"],"URL":"https:\/\/doi.org\/10.1515\/hsz-2024-0149","relation":{},"ISSN":["1431-6730","1437-4315"],"issn-type":[{"value":"1431-6730","type":"print"},{"value":"1437-4315","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,1]]}}}